Forsidebilde av showet Ozempic and Your Brain — What the Science Says

Ozempic and Your Brain — What the Science Says

Podkast av Inception Point AI

engelsk

Teknologi og vitenskap

Tidsbegrenset tilbud

2 Måneder for 19 kr

Deretter 99 kr / MånedAvslutt når som helst.

  • 20 timer lydbøker i måneden
  • Eksklusive podkaster
  • Gratis podkaster
Kom i gang

Les mer Ozempic and Your Brain — What the Science Says

Dr. Ben Synth explores the cutting-edge neuroscience of GLP-1 drugs like Ozempic, revealing how these medications affect memory, mood, and the brain's reward system. From Alzheimer's prevention to addiction pathways, discover what happens when a weight-loss drug rewires your brain. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.

Alle episoder

2 Episoder

episode Ozempic and Your Brain — What the Science Says - Mood on the Scale: The Serotonin Puzzle cover

Ozempic and Your Brain — What the Science Says - Mood on the Scale: The Serotonin Puzzle

Ben Synth examines how semaglutide affects mental health, exploring evidence that shows the diabetes and weight-loss drug may improve mood for some while triggering depression in others. The episode covers animal studies, massive patient databases, clinical trials, and the complex relationship between GLP-1 receptors, serotonin systems, and individual brain chemistry that could explain these contradictory outcomes. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. april 2026 - 23 min
episode Ozempic and Your Brain — What the Science Says - The Alzheimer's Question cover

Ozempic and Your Brain — What the Science Says - The Alzheimer's Question

Dr. Ben Synth examines groundbreaking research linking semaglutide to potential Alzheimer's protection, analyzing studies of over 100 million patients showing 40-70% risk reduction. He explores the biological mechanisms, discusses critical caveats about observational data versus randomized trials, and explains why GLP-1 receptors in the brain matter for memory and cognition. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. april 2026 - 24 min
Registrer deg for å lytte
Enkelt å finne frem nye favoritter og lett å navigere seg gjennom innholdet i appen
Enkelt å finne frem nye favoritter og lett å navigere seg gjennom innholdet i appen
Liker at det er både Podcaster (godt utvalg) og lydbøker i samme app, pluss at man kan holde Podcaster og lydbøker atskilt i biblioteket.
Bra app. Oversiktlig og ryddig. MYE bra innhold⭐️⭐️⭐️

Velg abonnementet ditt

Mest populær

Tidsbegrenset tilbud

Premium

20 timer lydbøker

  • Eksklusive podkaster

  • Ingen annonser i Podimo shows

  • Avslutt når som helst

2 Måneder for 19 kr
Deretter 99 kr / Måned

Kom i gang

Premium Plus

100 timer lydbøker

  • Eksklusive podkaster

  • Ingen annonser i Podimo shows

  • Avslutt når som helst

Prøv gratis i 14 dager
Deretter 169 kr / måned

Prøv gratis

Bare på Podimo

Populære lydbøker

Ofte stilte spørsmål

Flere spørsmål og svar
Kom i gang

2 Måneder for 19 kr. Deretter 99 kr / Måned. Avslutt når som helst.